E. Granzer
Impact in
- Biotechnology top 5%
- Microbial Metabolism and Applications
- Marine Sponges and Natural Products
- Pharmacology top 10%
- Microbial Natural Products and Biosynthesis
Papers in
-
- Glycosylation and Glycoproteins Research 3
-
- Chemical synthesis and pharmacological studies 2
- Synthesis and Reactivity of Sulfur-Containing Compounds 2
- Co-authors
- G. Ruhenstroth‐Bauer (7 shared papers)B. v. Kerékjártó (6 shared papers)G. Beck (6 shared papers)Heiner Jendralla (6 shared papers)Wilhelm Bartmann (6 shared papers)R. A. Krause (5 shared papers)E. Baader (5 shared papers)Andreas Bergmann (4 shared papers)
- Journals
- Journal of Medicinal Chemistry (3 papers)Die Naturwissenschaften (3 papers)Cellular and Molecular Life Sciences (2 papers)Tetrahedron Letters (2 papers)BioScience (1 paper)
- Partner nations
- GermanySwitzerlandAustria
In The Last Decade
E. Granzer
29 papers receiving 449 citations
Peers
Comparison fields: 5 of 82
- Biotechnology 99
- Pharmacology 132
- Organic Chemistry 200
- Microbiology 4
- Molecular Biology 222
Countries citing papers authored by E. Granzer
This map shows the geographic impact of E. Granzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Granzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Granzer more than expected).
Fields of papers citing papers by E. Granzer
This network shows the impact of papers produced by E. Granzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Granzer. The network helps show where E. Granzer may publish in the future.
Co-authors
The 25 scholars most cited alongside E. Granzer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 118 | |
| 2 | 1990 | 63 | |
| 3 | 1990 | 52 | |
| 4 | 1991 | 44 | |
| 5 | 1962 | 33 | |
| 6 | 1962 | 32 | |
| 7 | 1960 | 21 | |
| 8 | 1986 | 19 | |
| 9 | 1962 | 18 | |
| 10 | 1988 | 15 | |
| 11 | 1964 | 14 | |
| 12 | 1970 | 13 | |
| 13 | 1993 | 12 | |
| 14 | 1987 | 11 | |
| 15 | 1994 | 10 | |
| 16 | 1964 | 8 | |
| 17 | 1952 | 6 | |
| 18 | 1963 | 6 | |
| 19 | HCG 004, a new highly potent hypolipidaemic drug. | 1973 | 5 |
| 20 | 1958 | 5 |
About E. Granzer
E. Granzer is a scholar working on Molecular Biology, Organic Chemistry, Biochemistry, Surgery and Pharmacology, having authored 29 papers that have together received 533 indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (3 papers), Inflammatory mediators and NSAID effects (3 papers), Computational Drug Discovery Methods (3 papers), Chemical synthesis and pharmacological studies (2 papers), Biochemical Acid Research Studies (2 papers), Amino Acid Enzymes and Metabolism (2 papers), Synthesis and Reactivity of Sulfur-Containing Compounds (2 papers) and Cholesterol and Lipid Metabolism (2 papers). The work is most often cited by research in Biotechnology (99 citations), Pharmacology (132 citations), Organic Chemistry (200 citations), Microbiology (4 citations) and Molecular Biology (222 citations). E. Granzer has collaborated with scholars based in Germany, Switzerland and Austria. Frequent co-authors include G. Ruhenstroth‐Bauer, B. v. Kerékjártó, G. Beck, Heiner Jendralla, Wilhelm Bartmann, R. A. Krause, E. Baader, Andreas Bergmann, Günter Fred Fuhrmann and Kurt Keßeler. Their work appears in journals such as Journal of Medicinal Chemistry, Die Naturwissenschaften, Cellular and Molecular Life Sciences, Tetrahedron Letters and BioScience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.